Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma

Clinical trial NCT03283046 · WITHDRAWN

Trial details

NCT number: NCT03283046
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic Multiple Myeloma

Start date: 2017-10-01
Primary completion: 2020-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.